Skip to content

Menu

LexBlog, Inc. logo
CommunitySub-MenuPublishersChannelsProductsSub-MenuBlog ProBlog PlusBlog PremierMicrositeSyndication PortalsAboutContactResourcesSubscribeSupport
Join
Search
Close

More FTC Civil Enforcement for COVID-19 and CBD Cancer Treatment Claims

By Amanda Beane, Jason Howell, Jared Bryant & Tommy Tobin on May 4, 2020
Email this postTweet this postLike this postShare this post on LinkedIn

On April 28, 2020, the FTC announced a preliminary order in a civil enforcement action against a supplement manufacturer that allegedly made false and unsubstantiated claims regarding COVID-19 and cancer. Specifically, the FTC alleged that Whole Leaf Organics had marketed its “Thrive” product as an “anti viral wellness booster” that treated, prevented, or reduced the risk of COVID-19. The FTC also alleged that Whole Leaf Organics marketed three products containing cannabidiol (CBD) as effective cancer treatments.

The FDA had already issued a warning letter in November 2019 to Whole Leaf Organics for making unapproved drug claims about its CBD-infused products. But according to the FTC, the problematic claims remained on the company’s website months later.

In a statement announcing the preliminary order in which the company agreed to cease making COVID-19 and cancer-related claims, the FTC Bureau of Consumer Protection Director Andrew Smith noted: “There’s no proof that any product will prevent or treat COVID-19 or that any CBD product will treat cancer. Let’s be clear: companies making these claims can look forward to an FTC lawsuit like this one.”

Photo of Tommy Tobin Tommy Tobin
Read more about Tommy TobinEmail
  • Posted in:
    Corporate & Commercial
  • Blog:
    Consumer Protection Review
  • Organization:
    Perkins Coie LLP
  • Article: View Original Source

LexBlog, Inc. logo
Facebook LinkedIn Twitter RSS
Real Lawyers
99 Park Row
  • About LexBlog
  • Careers
  • Press
  • Contact LexBlog
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Terms of Service
  • RSS Terms of Service
  • Products
  • Blog Pro
  • Blog Plus
  • Blog Premier
  • Microsite
  • Syndication Portals
  • LexBlog Community
  • 1-800-913-0988
  • Submit a Request
  • Support Center
  • System Status
  • Resource Center

New to the Network

  • Pro Policyholder
  • The Way on FDA
  • Crypto Digest
  • Inside Cybersecurity & Privacy Law
  • La Oficina Legal Ayala Hernández
Copyright © 2022, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo